CFH Management

CFH Management GmbH is a private equity firm based in Leipzig, Germany, established in 1996. The firm focuses on investing in equity and mezzanine financing, targeting start-ups and medium-sized companies, particularly in the Saxony region. CFH operates through its own raised funds, executing venture capital investments via its managed fund TGFS and pursuing growth investments and smaller management buyouts through WMS. As a subsidiary of Süd BG, CFH Management is committed to fostering the development of emerging businesses and contributing to regional economic growth.

Jan Thomas Alter

Senior Investment Manager

Tam Dau

Junior Investment Manager

Gisbert Enkel

Managing Director

Thomas Mackiol

Investment Manager

Andreas Müller

Investment Director

Birthe Ross

Investment Manager

Friedemann Stier

Investment Director

Thomas Tettenborn

Investment Director

7 past transactions

CORTEX Biophysik

Funding Round in 2013
CORTEX Biophysik GmbH is a German company based in Leipzig, specializing in the development, manufacturing, and sale of metabolic stress testing systems. The company offers a range of products, including the MetaMax 3X and MetaMax 3B systems, METASOFT software, and the METALYZER stationary CPX-system, among others. These products cater to various markets, including sports medicine, cardiology, pulmonology, and rehabilitation medicine, as well as serving the needs of trainers and sports scientists. Recognized as a leader in mobile ergospirometry, CORTEX provides innovative solutions for cardiopulmonary diagnostics in high-performance sports and fitness centers. Established in 1991, the company has built a strong reputation within its field.

Novihum Technologies

Series A in 2013
Novihum Technologies GmbH, located in Dresden, Germany, specializes in the production of a natural soil enhancer derived from lignite. Founded in 2012, the company emerged from research conducted at the Technical University of Dresden in the 2000s. Novihum Technologies established its first industrial-scale production facility in Dortmund, Germany, in 2016, supported by venture capital partners and the European Union. The company has a dedicated team of soil, plant, and production experts and currently employs around 30 individuals. Novihum Technologies successfully supplies its innovative product to customers across Europe, North America, and other regions, contributing to sustainable agriculture and improved soil health.

Dr. Födisch Umweltmesstechnik

Private Equity Round in 2012
Dr. Födisch Umweltmesstechnik AG manufactures and develops environmental measuring devices for the determination of exhaust gas parameters, dust, and flow. Its product portfolio includes simple filter controllers, dust concentration measuring devices, gas analyzers, and flow measuring devices; and engineering and maintenance services. The company designs and supplies measuring systems for process and official monitoring of air pollutants. Its products are used in power plants and waste incinerators. The company sells its products through distributors in Europe, the Middle East, and Asia. Dr. Födisch Umweltmesstechnik AG was founded in 1991 and is based in Markranstädt, Germany with additional offices in Kriftel, Lappersdorf, Herne, Mülheim, and Lübeck, Germany; and China.

Omeras

Private Equity Round in 2010
Omeras GmbH, established in 1839 and based in Lauter, Germany, specializes in metal processing and enameling. The company manufactures a diverse range of enameled cookware, which includes frying pans, ovenproof dishes, baking trays, aroma and rectangular roasters, enameled asparagus and pasta pots, and enameled bread bins. In addition to its cookware offerings, Omeras produces enameled products designed for architectural applications, specifically for use in tunnel systems and public transportation infrastructure. This includes cladding panels for walls, roofs, and entrances, as well as products tailored for tunnel linings and subway stations.

Vivoryon Therapeutics

Series B in 2009
Vivoryon Therapeutics is a Germany based biopharmaceutical company engaged in the activities of research and development, preclinical and clinical trials. It is focused on the development of therapeutic products for the treatment of Alzheimer's disease and cancer. The company's pipeline products includes PQ912, PQ1565 and PQ-family.

MediaInterface

Series A in 2006
MediaInterface, founded in 1997 and located in Dresden, Germany, specializes in the design and development of software for speech recognition. The company offers Software as a Service (SaaS) products that focus on voice-based applications, particularly for documentation processes in the healthcare sector. MediaInterface's solutions are noted for their robustness against ambient noise, high recognition accuracy, and the ability to be customized to meet specific customer requirements. Through its innovative language technology, MediaInterface aims to enhance efficiency and accuracy in various documentation tasks.

Novaled

Series B in 2005
Novaled AG is a world-class technology provider in organic light-emitting diode (OLED) technologies. With expertise in synthetic and analytical chemistry, it offers complete solutions for the organic electronic markets, commercializing Novaled's Doping technology and materials. Novaled has developed long-term partnerships with major OLED players worldwide. Its strong IP position in OLED technology is based on more than 500 patents granted or pending. In operation since March 2003, Novaled is headquartered in Dresden, Germany with branch offices in Asia.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.